Citation:Durrani K, Kempen JH, Foster SC, for Group SITED (SITE) R. Authors reply to Letter to the Editor- In response to: Comment on Durrani et al."s "Adalimumab for Ocular Inflammation". Ocul Immunol Inflamm 2017;:1.Download CitationPubMed DOI BibTex Tagged XML Date Published:2017 Oct 18See also: Infectious Disease, October 2017, All, 2017Last updated on 11/02/2017 PubMedDOI
